| Stereochemistry | ABSOLUTE |
| Molecular Formula | C30H33N5O2 |
| Molecular Weight | 495.6153 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1N=NC(C)=C1C2=CN=C3C(=C2)N([C@@H](C4CCOCC4)C5=CC=CC=C5)C6=C3C=CC(=C6)C(C)(C)O
InChI
InChIKey=KGERZPVQIRYWRK-GDLZYMKVSA-N
InChI=1S/C30H33N5O2/c1-19-28(34(4)33-32-19)22-16-26-27(31-18-22)24-11-10-23(30(2,3)36)17-25(24)35(26)29(20-8-6-5-7-9-20)21-12-14-37-15-13-21/h5-11,16-18,21,29,36H,12-15H2,1-4H3/t29-/m1/s1
| Molecular Formula | C30H33N5O2 |
| Molecular Weight | 495.6153 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 5.0 nM [IC50] |
